Eliezer J. Barreiro
Rio De Janeiro, RJ 21941902, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Regioselective Nucleophilic Aromatic Substitution: Theoretical and Experimental Insights into 4-Aminoquinazoline Synthesis as a Privileged Structure in Medicinal Chemistry.
Journal: Molecules (Basel, Switzerland)
Published: November 17, 2024
Novel Agonists of Adenosine Receptors in Animal Model of Acute Myocardial Infarction.
Journal: Drug design, development and therapy
Published: April 03, 2024
In vitro results with minimal blood toxicity of a combretastatin A4 analogue.
Journal: Investigational new drugs
Published: March 05, 2024
Antiproliferative Activity of N-Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition.
Journal: Biomedicines
Published: February 26, 2024
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 13, 2024
Stereochemical insights into β-amino-N-acylhydrazones and their impact on DPP-4 inhibition.
Journal: RSC advances
Published: January 17, 2024
Antihypertensive Effect of New Agonist of Adenosine Receptor in Spontaneously Hypertensive Rats.
Journal: Arquivos brasileiros de cardiologia
Published: June 20, 2023
N-acylhydrazone derivative modulates cell cycle regulators promoting mitosis arrest and apoptosis in estrogen positive MCF-7 breast cancer cells.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: April 26, 2023
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent.
Journal: Pharmaceutics
Published: March 07, 2023
Design, Synthesis and Phenotypic Profiling of Simplified Gedatolisib Analogues.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 30, 2022
Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 29, 2022
Comparative chemical and biological hydrolytic stability of homologous esters and isosteres.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 14, 2022
Last Updated: 09/26/2026